Cross Country Healthcare, Inc.
NASDAQ:CCRNMedical - Care Facilities
+$0.01 today
- Market cap
- $428.06M
- Beta
- 0.45
- P/E (TTM)
- -4.2
- EPS (TTM)
- -$3.13
Volume 1.78M
Average 0.64M
CCRN Effect of Forex Changes
Change in reported cash caused by exchange-rate movements on foreign-currency balances.
Cross Country Healthcare, Inc.NASDAQ: CCRN
Effect of Forex Changes · Q1 FY2026 · quarter ended Mar 2026
Effect of forex changes grows, but more slowly than its trailing trend
Q1 FY2026 effect of forex changes of $7K (cash outflow) rose 16.7% year over year, behind the +200.0% change in trailing-twelve-month effect of forex changes.
Context
- Effect of forex changes amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Effect of forex changes increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +16.7% toward the trailing-twelve-month pace of +200.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Effect of Forex Changes history
USD · from the cash flow
- Latest · FY2025
- 21K USD
- Year-over-year change
- +250.0%
- 4-year CAGR
- +36.8%
| Period | Period end | Effect of Forex Changes | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 21K | +250.0% |
| FY2024 | 2024-12-31 | (14K) | -275.0% |
| FY2023 | 2023-12-31 | 8K | +188.9% |
| FY2022 | 2022-12-31 | (9K) | -250.0% |
| FY2021 | 2021-12-31 | 6K | — |
Effect of Forex Changes vs competitors
How CCRN compares with its peers on the latest reported figures
- Peers report in different currencies, so effect of forex changes is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +200.0% is the highest of 4, against a peer median of +142.7%.
- Effect of forex changes amounts to 0.0% of revenue for CCRN, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
AUNAAuna S.A. | LTM Mar 2026 | PEN 20.59M PEN | +178.3% | — | 0.5% |
| LTM Mar 2026 | $740K USD | +142.7% | -17.5% | 0.3% | |
| LTM Mar 2026 | $20K USD | +200.0% | — | 0.0% | |
MCTACharming Medical Limited Class A Ordinary Shares | FY2024 | $4.62K USD | -56.1% | — | 0.1% |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding CCRN) | — | +142.7% | -17.5% | 0.0% | |
Competitors are the stored peer set for CCRN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 132M | 185.98M | 72.63M | (14.56M) | (94.85M) |
| Depreciation & Amortization | 9.85M | 12.58M | 18.35M | 18.2M | 16.79M |
| Deferred Income Tax | (9.93M) | 5.11M | 1.3M | (1.94M) | 10.07M |
| Stock-Based Compensation | 6.89M | 7.39M | 6.58M | 6.03M | 7.14M |
| Change in Working Capital | (237.26M) | (103.71M) | 127.48M | 87.63M | 30.47M |
| Accounts Receivables | (318.42M) | (153.23M) | 251.43M | 128.33M | 56.73M |
| Inventory | (83.29M) | 0 | 0 | 0 | 0 |
| Accounts Payables | 83.29M | 0 | (126.61M) | (29.75M) | 0 |
| Other Working Capital | 81.16M | 49.52M | 2.66M | (10.95M) | (26.26M) |
| Other Non-Cash Items | 12.82M | 26.7M | 22.16M | 24.77M | 78.63M |
| Operating Cash Flow | (85.62M) | 134.05M | 248.5M | 120.12M | 48.25M |
| Capital Expenditures | (7.17M) | (8.79M) | (13.97M) | (8.71M) | (8.16M) |
| Acquisitions (Net) | (26.88M) | (35.09M) | 199K | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (34.05M) | (43.87M) | (13.78M) | (8.71M) | (8.16M) |
| Debt Repayment | 127.68M | 32.34M | (150.68M) | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (2.23M) | (35.29M) | (57.65M) | (37.31M) | (6.83M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (6.35M) | (84.65M) | (12.91M) | (9.54M) | (6.17M) |
| Financing Cash Flow | 119.09M | (87.6M) | (221.24M) | (46.85M) | (13.01M) |
| Effect of Forex Changes | 6K | (9K) | 8K | (14K) | 21K |
| Net Change in Cash | (564K) | 2.57M | 13.49M | 64.54M | 27.11M |
| Free Cash Flow | (92.79M) | 125.26M | 234.52M | 111.4M | 40.09M |
Cross Country Healthcare, Inc.
NASDAQ:CCRN
Intrinsic Alpha fair value
Locked
Current Price
$13.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.